Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02954315
Other study ID # 930524
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 25, 2016
Est. completion date April 30, 2018

Study information

Verified date October 2018
Source University of California, Davis
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Investigators hypothesize that regular consumption of almonds will augment the long chain fatty acid profile and the alpha-tocopherol levels, improve the skin barrier function, and improve the appearance of facial wrinkles in post-menopausal women.


Description:

Primary Endpoint:

A) Change in wrinkle depth. Full facial photographs will be obtained at baseline, 8 weeks, and 16 weeks. The images will be obtained with the 3D Clarity Pro® Facial Modeling and Analysis System (Brigh-Tex BioPhotonics, San Jose, CA) that has standardized positioning and lighting. This system can assess average wrinkle depth. The PI has already validated this measurement tool against standard clinical grading of facial wrinkles[13].

Secondary Endpoint:

A) Change in clinical appearance of facial wrinkles on lateral canthi: Two blinded dermatologists will grade the photographs obtained at each of the time points on the lateral canthi ("crow's feet"). The dermatologists will not know which group the subjects were in.

B) Change in facial sebum production through the use of a Sebumeter, a commonly used device that measures sebum excretion rate [13,17]. Sebum excretion rate will be measured at baseline, 8 weeks, and 16 weeks.

C) Change in serum and sebum lipid profiles obtained through the use of Sebutapes at baseline, 8 weeks, and 16 weeks.

D) Change in the serum and sebum lipid profile for assessment of long chain/short chain fatty acid ratios and the NS ceramide content.

Procedures Involved This study will be a 16-week supplementation study that utilizes two study groups: 1) Control group 2) Almond supplementation: 20% energy intake. This will be a randomized, rater-blinded, controlled study.

There will be a total of 30 subjects:

Control Group: n=15 Almond Supplementation: n=15

The subjects will be recruited from the UC Davis Dermatology Department, the surrounding clinics in a 25 mile radius, and the general population in the Davis and Sacramento areas. The greater Sacramento area has a population of over 2 million to draw from and recruitment will be conducted through the use of Social Media and flyer based recruitment.

Investigators will collect medical history and current medications from study participants- this is outlined in the HIPAA form. The two intervention groups will consist of those receiving almonds and those that are receiving a calorie matched snack. The almond dose will be provided as 20% of total energy (20% E) in the diet. This dose was selected based on a previous randomized trial examining lipid parameters in response to 0, 10%, and 20% E as dietary almonds and a recent meta-analysis of intervention trials of tree nuts [23,24]. The control snack will be a typical western diet snack. The calorie-matched control snack will be commercially available individually wrapped food products such as a small granola bar + pretzels. Once a subject has met inclusion criteria and has signed IRB consent, anthropometric data will be obtained, 3-24 hour recall will be collected by phone, skype, or in person by a Registered Dietitian, training will be provided for recording dietary records, and estimated caloric needs will be calculated. Estimated energy needs (EER) will be determined using the Mifflin-St. Jeor equation and total daily energy needs (TDE) calculated as EER x activity factor of 1.3-1.5 for sedentary to average activity, or a higher activity level as indicated. A representative example of a 60 year old woman, 5'4", 140 pounds with typical activity level yields TDE of approximately 1,600 - 1,800 kcal/day, and 20% E of 320-360 kcal/day. The dose of almonds would be 2 ounces (equal to 23 whole kernels)/day, providing 328 calories.


Recruitment information / eligibility

Status Completed
Enrollment 31
Est. completion date April 30, 2018
Est. primary completion date April 30, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Postmenopausal women

- Fitzpatrick skin types 1 and 2

- Able to follow dietary intervention and attend all study visits

Exclusion Criteria:

- Those with a nut allergy

- Smoking:

- Current smokers

- Those that have smoked within the past year

- Former smokers with greater than a 20 pack-year history of smoking within the past 20 years will be excluded.

- Those with an autoimmune photosensitive condition or a known genetic condition with a deficiency in collagen production (such as Ehler-Danlos)

- Those that already obtain 20% of their energy intake from nut consumption

- Those with implausible reported energy intakes of <1,000 kcal/d or >3,000 kcal/d

- Individuals who are unwilling to discontinue high antioxidant supplements and daily food sources listed below, during the washout and intervention.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Almonds


Locations

Country Name City State
United States UC Davis Department of Dermatology, Clinical Trials Unit Sacramento California

Sponsors (1)

Lead Sponsor Collaborator
University of California, Davis

Country where clinical trial is conducted

United States, 

References & Publications (1)

Alasalvar C, Bolling BW. Review of nut phytochemicals, fat-soluble bioactives, antioxidant components and health effects. Br J Nutr. 2015 Apr;113 Suppl 2:S68-78. doi: 10.1017/S0007114514003729. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in wrinkle depth 16 weeks
Secondary Change in clinical appearance of facial wrinkles on lateral canthi 16 weeks
Secondary Change in facial sebum production through the use of a Sebumeter 16 weeks
Secondary Change in serum and sebum lipid profiles 16 weeks
Secondary Change in the serum and sebum lipid profile for assessment of long chain/short chain fatty acid ratios and the NS ceramide content 16-weeks
See also
  Status Clinical Trial Phase
Not yet recruiting NCT00495443 - Enhanced Safety Aesthetic Laser System N/A
Completed NCT04586816 - Randomized, Double-Blind Evaluation of Maple Leaf Extract (Maplifa) for Photoaging N/A
Completed NCT01460927 - TriActive+ Radiofrequency (RF) for Non-invasive Treatment of Wrinkles & Rhytides N/A
Withdrawn NCT04994990 - Effective OnabotulinumtoxinA Dose Response Study for Upper Facial Wrinkles N/A
Completed NCT01859611 - TriActive+ Radiofrequency (RF) for Non-Invasive Treatment of Wrinkles and Rhytides N/A
Completed NCT05807412 - Spread of PrabotulinumtoxinA-xvfs Versus OnabotulinumtoxinA in the Treatment of Forehead Rhytides Early Phase 1
Completed NCT03776461 - Fractional Radiofrequency for the Treatment and Reduction of Facial Wrinkles N/A
Completed NCT05514834 - BCT-HA Kit for Dehydrated and Wrinkled Skin Early Phase 1
Enrolling by invitation NCT06104514 - Safety and Efficacy of SofWave Treatment to Lift the Upper Lip and Improve the Peri-Oral Rhytids N/A
Completed NCT03286283 - The Use of J-Plasma® for Dermal Resurfacing N/A
Completed NCT05041465 - The Cosmetic Effect of Mineral Clay Masks N/A
Completed NCT06421207 - Open Label Study Exploring Tissue Histopathology After Ellacor® Procedure in an Abdominoplasty Model. N/A
Completed NCT04185909 - Renuvion Dermal System for Dermal Resurfacing N/A
Completed NCT03831477 - Clinical Evaluation of Fractional Radiofrequency for the Treatment and Reduction of Facial Wrinkles N/A
Completed NCT05517538 - Split-face Study: Cosmetic Botulinum Toxin Type A Injection Under Electromyography-guidance Versus Conventional Palpation Technique N/A
Active, not recruiting NCT04162496 - Restylane Refyne for Correction of Horizontal Neck Rhytides N/A
Withdrawn NCT02659124 - Comparison of AmnioFix Laser and Standard of Care Treatment N/A